• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE MOLECULAR SYSTEMS, INC. COBAS MPX TEST, CE-IVD; ASSAY, HYB AND/OR NUCLEIC ACID AMP FOR DETECTION OF HCV RNA, HIV RNA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE MOLECULAR SYSTEMS, INC. COBAS MPX TEST, CE-IVD; ASSAY, HYB AND/OR NUCLEIC ACID AMP FOR DETECTION OF HCV RNA, HIV RNA Back to Search Results
Catalog Number 06997716190
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/13/2019
Event Type  malfunction  
Manufacturer Narrative
The investigation of this issue is on-going and final conclusions will be shared in a follow-up report.The material number for the cobas mpx test, 480t, (b)(4).The udi for the cobas mpx test, 480t, us-ivd is (b)(4).------ (b)(4).
 
Event Description
A customer from (b)(6) alleged discrepant results between serology and cobas mpx testing for a donor, with the cobas mpx test consistently generating non-reactive results.Depending on the serology test used, a mixture of positive and negative serology results were generated.The donor was diagnosed with lymphadenopathy, and it was indicated that he is a new donor.The blood donation was discarded.
 
Manufacturer Narrative
The donor sample from (b)(6) 2019 collection was sent to a reference lab for testing with the abbott real-time hiv-1 viral load assay.The result was target not detected, which confirms (b)(6) was not present and additional testing, including sequence analysis, would not be possible.No information was provided on any additional follow up blood draws or testing for the donor.Roche medical and scientific affairs was consulted with details of the case provided.They explained that a (b)(6) antigen test ten days following the first reaction, with no serology reactivity is unlikely for a true (b)(6) patient.With the totality of the data considered, as well as the investigation (review of qc kit release, non-conformance, etc) the cobas mpx assay has been determined to be functioning as intended.A (b)(6) result with the p24 and serology test assay is suspected.------ (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS MPX TEST, CE-IVD
Type of Device
ASSAY, HYB AND/OR NUCLEIC ACID AMP FOR DETECTION OF HCV RNA, HIV RNA
Manufacturer (Section D)
ROCHE MOLECULAR SYSTEMS, INC.
1080 us highway 202 south
branchburg NJ 08876
Manufacturer Contact
stacie-ann creighton
1080 us hwy 202 s
na
branchburg, NJ 08876
9082537112
MDR Report Key9639112
MDR Text Key184179527
Report Number2243471-2020-00002
Device Sequence Number1
Product Code QHO
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/28/2020
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2020
Device Catalogue Number06997716190
Device Lot NumberE21552
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/31/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age19 YR
-
-